More than two years into our partnership with Micromedex, we continue to see the value of DynaMedex and how the combined solution benefits all clinicians across the continuum of care. DynaMedex will continue to serve as a one-stop-shop for clinicians at the point of care.

IPSWICH, Mass. (PRWEB)
October 11, 2022

EBSCO Information Services (EBSCO) and Merative add a new face to their integrated clinical decision support solution. Under a new name, DynaMedex™, formerly DynaMed® and Micromedex® with Watson™, continues to enhance clinical decision support and operations for healthcare providers and health systems.

DynaMedex offers the power of combining two award-winning disease and drug solution suites — DynaMed and Micromedex — into one seamless experience. DynaMed quickly surfaces peer-reviewed clinical content, with recommendations supported by the latest clinical evidence from comprehensive disease topics, health conditions, and abnormal findings to highly focused topics on evaluation, differential diagnosis and management. Micromedex is a leading evidence-based online reference database for medication information. More than 3,300 hospitals and health systems worldwide rely on Micromedex to support decision-making in medication therapy management, toxicology, alternative medicine and patient education.

DynaMed was named 2022 Best in KLAS for Clinical Decision Support for the second consecutive year and is a flagship product of EBSCO’s Clinical Decisions suite, which received Frost & Sullivan’s 2022 North America Product Leadership award.

Since the partnership began in March 2020, DynaMedex has continued to grow and increase its offerings connected to the DynaMedex ecosystem. With the integration of – DynaMed Decisions, a tool designed to drive meaningful patient-clinician interactions, clinicians have easy access to additional resources to streamline their workflow and support shared decision-making. The addition of Isabel, a diagnostic decision support tool available in DynaMed, enables clinicians to experience an improved diagnosis quality, leading to cost-effective patient care.

EBSCO Executive Vice President of Clinical Decisions Betsy Jones says that the solution’s new name is indicative of the company’s intent to move the resource forward as EBSCO Clinical Decisions’ new flagship product. “More than two years into our partnership with Micromedex, we continue to see the value of DynaMedex and how the combined solution benefits all clinicians across the continuum of care. DynaMedex will continue to serve as a one-stop-shop for clinicians at the point of care.”

DynaMed Editor in Chief Peter Oettgen, MD, FACC, FAHA, FACP, says that the breadth and depth of the evidence-based content available in DynaMedex has grown tremendously in the last few years. “With DynaMedex, clinicians have access to the most current drug and disease content, extensive coverage of specialty topics, and recommendations that are based on the latest evidence and clinical practice guidelines, providing decision support when they need it.”

With the leading drug information resources, together with the most current disease and condition topics, across the most specialties and unique tools for differential diagnosis and shared-decision-making, DynaMedex is not just a name change, it is the beginning of a new era in clinical care. For more information on DynaMedex, visit http://www.dynamedex.com.

About EBSCO Information Services

EBSCO Information Services (EBSCO) is the preeminent provider of online research content and search technologies serving academic, school and public libraries; healthcare and medical institutions; corporations; and government agencies around the world. EBSCO’s Clinical Decisions suite of products is designed to improve patient care by providing healthcare professionals with the most current, evidence-based answers to clinical questions as they arise at the point of care. For more information, visit the EBSCO website at: http://www.ebsco.com.

For more information, please contact:

Jessica Holmes

EBSCO Information Services

Communications Director

978-414-0420

jmholmes@ebsco.com

Share article on social media or email: